Capricor Therapeutics (CAPR)
NASDAQ:CAPR
Holding CAPR?
Track your performance easily

Capricor Therapeutics (CAPR) Financial Statements

827 Followers

Capricor Therapeutics Financial Overview

Capricor Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.93; its P/E ratio is -21.18; Capricor Therapeutics is scheduled to report earnings on November 13, 2024, and the estimated EPS forecast is $-0.36. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 3.97M$ 4.91M$ 12.09M$ 6.19M$ 3.92M
Gross Profit$ 3.97M$ 4.91M$ 12.09M$ 6.19M$ 3.92M
EBIT$ -11.00M$ -9.79M$ -1.28M$ -6.86M$ -7.37M
EBITDA$ -10.64M$ -9.46M$ -973.68K$ -6.59M$ -7.11M
Net Income Common Stockholders$ -11.00M$ -9.79M$ -762.09K$ -6.39M$ -7.35M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 29.46M$ 39.92M$ 39.49M$ 28.52M$ 37.79M
Total Assets$ 38.28M$ 49.44M$ 58.73M$ 37.15M$ 46.01M
Total Debt$ 5.21M$ 5.40M$ 5.61M$ 5.79M$ 5.60M
Net Debt$ -24.25M$ -34.52M$ -33.88M$ -22.73M$ -32.19M
Total Liabilities$ 26.78M$ 31.01M$ 36.13M$ 38.94M$ 43.28M
Stockholders Equity$ 11.50M$ 18.43M$ 22.60M$ -1.79M$ 2.73M
Cash Flow-
Free Cash Flow$ -12.35M$ -1.88M$ -12.32M$ -9.43M$ -9.45M
Operating Cash Flow$ -12.29M$ -1.27M$ -11.59M$ -8.79M$ -9.42M
Investing Cash Flow$ 14.70M$ -9.50M$ -5.86M$ 7.72M$ 6.46M
Financing Cash Flow$ 2.07M$ 2.29M$ 23.17M$ 221.08K$ 2.19M
Currency in USD

Capricor Therapeutics Earnings and Revenue History

Capricor Therapeutics Debt to Assets

Capricor Therapeutics Cash Flow

Capricor Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis